Personalized Medicine Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

CHAPTER 1. Industry Overview of Personalized Medicine Market

1.1. Definition and Scope

1.1.1. Definition of Personalized Medicine

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Personalized Medicine Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Personalized Medicine Market By Product 

1.2.3. Personalized Medicine Market By Application

1.2.4. Personalized Medicine Market By End-use

1.2.5. Personalized Medicine Market By Region

 

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

 

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Personalized Medicine Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Personalized Medicine Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

 

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

 

CHAPTER 5. Personalized Medicine Market By Product

5.1. Introduction

5.2. Personalized Medicine Revenue By Product

5.2.1. Personalized Medicine Revenue (USD Million) and Forecast, By Product, 2020-2032

5.2.2. Personalized Medicine Therapeutics

5.2.2.1. Personalized Medicine Therapeutics Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.2. Pharmaceutical

5.2.2.2.1. Pharmaceutical Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3. Genomic Medicine

5.2.2.3.1. Genomic Medicine Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.4. Medical Devices

5.2.2.4.1. Medical Devices Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. Personalized Medicine Diagnostics

5.2.3.1. Personalized Medicine Diagnostics Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3.2. Genetic Testing

5.2.3.2.1. Genetic Testing Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3.3. Direct-To-Consumer (DTC) Diagnostics

5.2.3.3.1. Direct-To-Consumer (DTC) Diagnostics Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3.4. Esoteric Lab Services

5.2.3.4.1. Esoteric Lab Services Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3.5. Esoteric Lab Tests

5.2.3.5.1. Esoteric Lab Tests Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4. Personalized Nutrition & Wellness

5.2.4.1. Personalized Nutrition & Wellness Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.2. Retail Nutrition

5.2.4.2.1. Retail Nutrition Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.3. Complementary & Alternative Medicine

5.2.4.3.1. Complementary & Alternative Medicine Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5. Personalized Medical Care

5.2.5.1. Personalized Medical Care Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5.2. Telemedicine

5.2.5.2.1. Telemedicine Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5.3. Health Information Technology

5.2.5.3.1. Health Information Technology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 6. Personalized Medicine Market By Application

6.1. Introduction

6.2. Personalized Medicine Revenue By Application

6.2.1. Personalized Medicine Revenue (USD Million) and Forecast, By Application, 2020-2032

6.2.2. Oncology

6.2.2.1. Oncology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. Infectious disease

6.2.3.1. Infectious disease Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.4. Neurology or Psychiatry

6.2.4.1. Neurology or Psychiatry Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.5. Cardiovascular

6.2.5.1. Cardiovascular Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.6. Others

6.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 7. Personalized Medicine Market By End-use

7.1. Introduction

7.2. Personalized Medicine Revenue By End-use

7.2.1. Personalized Medicine Revenue (USD Million) and Forecast, By End-use, 2020-2032

7.2.2. Hospitals

7.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3. Diagnostic Centers

7.2.3.1. Diagnostic Centers Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.4. Research & Academic Institutes

7.2.4.1. Research & Academic Institutes Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.5. Others

7.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 8. North America Personalized Medicine Market By Country 

8.1. North America Personalized Medicine Market Overview

8.2. U.S.

8.2.1. U.S. Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

8.2.2. U.S. Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

8.2.3. U.S. Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

8.3. Canada

8.3.1. Canada Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

8.3.2. Canada Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

8.3.3. Canada Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

8.4. North America PEST Analysis

 

CHAPTER 9. Europe Personalized Medicine Market By Country

9.1. Europe Personalized Medicine Market Overview

9.2. U.K.

9.2.1. U.K. Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

9.2.2. U.K. Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

9.2.3. U.K. Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

9.3. Germany

9.3.1. Germany Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

9.3.2. Germany Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

9.3.3. Germany Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

9.4. France

9.4.1. France Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

9.4.2. France Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

9.4.3. France Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

9.5. Spain

9.5.1. Spain Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

9.5.2. Spain Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

9.5.3. Spain Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

9.6.2. Rest of Europe Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

9.6.3. Rest of Europe Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

9.7. Europe PEST Analysis

 

CHAPTER 10. Asia Pacific Personalized Medicine Market By Country

10.1. Asia Pacific Personalized Medicine Market Overview

10.2. China

10.2.1. China Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

10.2.2. China Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

10.2.3. China Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

10.3. Japan

10.3.1. Japan Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

10.3.2. Japan Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

10.3.3. Japan Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

10.4. India

10.4.1. India Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

10.4.2. India Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

10.4.3. India Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

10.5. Australia

10.5.1. Australia Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

10.5.2. Australia Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

10.5.3. Australia Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

10.6. South Korea

10.6.1. South Korea Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

10.6.2. South Korea Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

10.6.3. South Korea Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

10.7.2. Rest of Asia-Pacific Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

10.7.3. Rest of Asia-Pacific Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

10.8. Asia Pacific PEST Analysis

 

CHAPTER 11. Latin America Personalized Medicine Market By Country

11.1. Latin America Personalized Medicine Market Overview

11.2. Brazil

11.2.1. Brazil Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

11.2.2. Brazil Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

11.2.3. Brazil Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

11.3. Mexico

11.3.1. Mexico Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

11.3.2. Mexico Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

11.3.3. Mexico Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

11.4.2. Rest of Latin America Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

11.4.3. Rest of Latin America Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

11.5. Latin America PEST Analysis

 

CHAPTER 12. Middle East & Africa Personalized Medicine Market By Country 

12.1. Middle East & Africa Personalized Medicine Market Overview

12.2. GCC

12.2.1. GCC Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

12.2.2. GCC Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

12.2.3. GCC Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

12.3. South Africa

12.3.1. South Africa Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

12.3.2. South Africa Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

12.3.3. South Africa Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Personalized Medicine Revenue (USD Million) and Forecast By Product, 2020-2032

12.4.2. Rest of Middle East & Africa Personalized Medicine Revenue (USD Million) and Forecast By Application, 2020-2032

12.4.3. Rest of Middle East & Africa Personalized Medicine Revenue (USD Million) and Forecast By End-use, 2020-2032

12.5. Middle East & Africa PEST Analysis

 

CHAPTER 13. Player Analysis Of Personalized Medicine Market

13.1. Personalized Medicine Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Personalized Medicine Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

 

CHAPTER 14. Company Profile

14.1. Abbott

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Million), 2022

14.1.3.2. Abbott 2022 Personalized Medicine Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. ASURAGEN, INC.

14.3. Cepheid, Inc. (Danaher Corporation)

14.4. Dako A/S

14.5. Decode Genetics, Inc.

14.6. Exact Sciences Corporation

14.7. Exagen Inc.

14.8. GE Healthcare

14.9. Illumina, Inc.

14.10. QIAGEN